Virtus Lifesci Biotech Clinical Trials ETF (BBC)
19.72 -0.26 (-1.30%) 13:09 ET [NYSE Arca]
19.64 x 3 19.69 x 3
Realtime by (Cboe BZX)
19.64 x 3 19.69 x 3
Realtime 19.80 -0.18 (-0.90%) 08:35 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | IBB | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 19.51 | 266.58 | 132.58 | ||
| High | 19.83 | 267.58 | 133.82 | ||
| Low | 19.50 | 265.51 | 131.97 | ||
| Last | 19.72 | 267.00 | 133.48 | ||
| Change | -0.26 | -0.62 | +0.74 | ||
| % Change | -1.30% | -0.23% | +0.56% | ||
| Volume | 20,332 | 73,629 | 448,037 | ||
| 20-Day Average Volume | 33,497 | 192,080 | 1,084,019 | ||
| Previous Close | 19.98 | 267.62 | 132.74 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.97 | 268.51 | 135.36 | ||
| 20-Day Raw Stochastic | 33.69% | 50.76% | 20.21% | ||
| 20-Day Relative Strength | 40.62% | 49.86% | 45.33% | ||
| Weighted Alpha | -35.79 | -0.08 | -3.89 | ||
| Today's Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 8% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.18% since 03/14/25 | +1.28% since 03/14/25 | -0.42% since 03/14/25 | ||
| Low | 19.44 on 03/18/25 | 263.62 on 03/17/25 | 131.97 on 03/21/25 | ||
| High | 20.26 on 03/17/25 | 269.00 on 03/20/25 | 136.57 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -9.32% since 02/21/25 | -0.50% since 02/21/25 | -3.80% since 02/21/25 | ||
| Low | 18.77 on 03/04/25 | 260.94 on 03/13/25 | 131.97 on 03/21/25 | ||
| High | 21.59 on 02/24/25 | 273.72 on 03/03/25 | 140.18 on 02/24/25 | ||
| 3-Month | |||||
| %Chg | -18.94% since 12/20/24 | +5.33% since 12/20/24 | +0.68% since 12/20/24 | ||
| Low | 18.77 on 03/04/25 | 252.13 on 12/30/24 | 130.81 on 01/13/25 | ||
| High | 25.28 on 01/07/25 | 274.19 on 02/05/25 | 142.80 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -32.44% since 09/20/24 | -6.19% since 09/20/24 | -9.70% since 09/20/24 | ||
| Low | 18.77 on 03/04/25 | 250.07 on 12/19/24 | 129.61 on 12/19/24 | ||
| High | 31.65 on 11/11/24 | 285.85 on 09/23/24 | 150.04 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,994 | 16,687,083 | 6,271,965 | ||
| Shares Outstanding, K | 300 | 62,349 | 47,250 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.08 | 0.73 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.239 on 12/20/24 | 0.919 on 12/18/24 | 0.121 on 03/18/25 | ||
| Next Ex-Dividends Date | 12/20/24 | 12/18/24 | 03/18/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.00 | 15.68 | ||